Personálne obsadenie

Zoznam zamestnancov z celouniverzitnej Centrálnej databázy osôb

Každý zamestnanec si môže v celouniverzitnej Centrálnej databáze osôb (link) sám zmeniť telefónne číslo, miestnosť, popis pracovnej pozície, webovú stránku. – Návod na úpravu kontaktných informácií (link, PDF).

  1. ADC Enalaprilat increases PPAR beta/delta expression, without influence on PPAR alpha and PPAR gamma, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy / Hana Černecká ... [et al.]
    In: European Journal of Pharmacology. - Vol. 714, No. 1-3 (2013), s. 472-477
  2. ADC Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy / Gabriel Dóka ... [et al.]
    In: Molecular and Cellular Biochemistry. - Vol. 432, No. 1-2 (2017), s. 79-89
  3. ADC mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats / P. Potúček ... [et al.]
    In: Clinical and Experimental Hypertension. - Vol. 39, No. 8 (2017), s 754-763
  4. ADC Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension / Michal Radik ... [et al.]
    In: International Journal of Medical Sciences. - Roč. 16, č. 6 (2019), s. 854-863
  5. ADC Pegfilgrastim and linagliptin potentiate chemoattraction of Ccr2 and Cd44 stem cells accompanied by alterations of cardiac Hgf, Igf-1 and Mcp-1 in daunorubicin cardiomyopathy / Jasna Šrankova ... [et al.]
    In: Journal of Pharmacy and Pharmacology. - Roč. 71, č. 9 (2019), s. 1440-1450
  6. ADC Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension / Jana Vetešková ... [et al.]
    In: Experimental Lung Research. - Roč. 45, č. 1-2 (2019), s. 30-41
  7. ADC Upregulation of SERCA2a following short- term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat / Marek Máťuš ... [et al.]
    In: Molecular and Cellular Biochemistry. - Vol. 403, No. 1-2 (2015), s. 199-208
  8. ADC L-arginine attenuates cardiac dysfunction, but further down-regulates alpha-myosin heavy chain expression in isoproterenol-induced cardiomyopathy / E. Kráľová ... [et al.]
    In: Basic & Clinical Pharmacology & Toxicology. - Vol. 117, No. 4 (2015), s. 251-260
  9. ADC Ramipril restores PPARbeta/delta and PPARgamma expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat / Hana Černecká ... [et al.]
    In: European Journal of Pharmacology. - Vol. 791 (2016), s. 244-253
  10. ADC Daunorubicin down-regulates the expression of stem cell markers and factors involved in stem cell migration and homing in rat heart in subchronic but not acute cardiomyopathy / Jasna Šranková ... [et al.]
    In: Basic & Clinical Pharmacology & Toxicology. - Vol. 119, No. 5 (2016), s. 443-452
  11. ADM Unbalanced upregulation of ryanodine receptor 2 plays a particular role in early development of daunorubicin cardiomyopathy / Dana Kučerová ... [et al.]
    In: American Journal of Translational Research. - Vol. 7, No. 7 (2015), s. 1280-1294
  12. ADN Voluntary exercise and testosterone therapy caused increase in percentage of Myh6 and expression of oxidative stress marker Cybb in left ventricles of rats / M. Radik ... [et al.]
    In: European Pharmaceutical Journal [elektronický zdroj]. - Roč. 63, č. 1 (2016), s. 12-15 [online]
  13. ADN Deteriorated gene expression of selected calcium transporters in streptozotocin-induced diabetic hearts of Wistar rats / Martin Dragún ... [et al.]
    In: European Pharmaceutical Journal [elektronický dokument]. - Roč. 65, č. 2 (2018), s. 1-3 [online]
  14. ADN Combination treatment with valsartan and amlodipine intensifies evening suppression of Bmal1 clock gene in kidneys of spontaneously hypertensive rats / Peter Potúček ... [et al.]
    In: European Pharmaceutical Journal [elektronický zdroj]. - Roč. 64, č. 1 (2017), s. 22-25 [online]
  15. AED Expresia faktorov ovplyvňujúcich migráciu a uchytenie kmeňových buniek v modeli antracyklínového srdcového zlyhania / Jasna Šranková ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 9. - ISBN 978-80-223-3651-2. - Bratislava : Univerzita Komenského, Farmaceutická fakulta, 2014. - S. 29-35
  16. AED Expresia ACE a ACE2 v pľúcach potkanov s monokritalínom indukovanou pľúcnou hypertenziou / Eva Malíková ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 12. - ISBN 978-80-223-4419-7. - Bratislava : Farmaceutická fakulta UK, 2017. - S. 28-33
  17. AED Expresia izoforiem kaveolínu-1 v aorte potkana s glukózovou intoleranciou vyvolanou nízkou dávkou streptozotocínu / Jasna Šranková ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 10. - ISBN 978-80-223-3924-7. - Bratislava : Farmaceutická fakulta UK, 2015. - S. 24-31
  18. AED Vplyv liečby ramiprilom na expresiu PPAR u chronickej antracyklínmi-indukovanej kardiomyopatie u potkanov / Hana Černecká ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 8. - ISBN 978-80-223-3470-9. - Bratislava : Univerzita Komenského v Bratislave, Farmaceutická fakulta, 2013. - S. 23-29
  19. AED Endotelínový systém v animálnom modeli izoprenalínom indukovanej hypertrofie srdca / Lenka Piváčková ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 7. - ISBN 978-80-223-3271-2. - Bratislava : Univerzita Komenského v Bratislave, Farmaceutická fakulta, 2012. - S. 83-89
  20. AED Sledovanie expresie vybraných transkripčných faktorov v epikardiálnom tuku explantovaných sŕdc v porovnaní s klinickými údajmi pacientov / Jana Mlynárová ... [et al.]
    In: Pokroky vo farmakológii v Slovenskej republike 7. - ISBN 978-80-223-3271-2. - Bratislava : Univerzita Komenského v Bratislave, Farmaceutická fakulta, 2012. - S. 109-114
  21. AEG Effects of testosterone on cardiac function in physically active rats / Ján Klimas ... [et al.]
    In: Journal of Hypertension. - Vol. 29, e-Supplement A (2011), s. e522
  22. AFC Regulation of daunorubicine-related cardiomyopathy: role of blood presure, oxidative stress, calcium pathways and PPAR pathways / Ján Kyselovič ... [et al]
    In: Nato Advanced Research Workshop. - Yalta : [s.n.], 2012. - S. 17-18
  23. AFG Disparate effect of single and co-administration of clarithromycin and furosemide on cardiac gene expression (Kcnq1, Cacna1c, Myh6, Myh7 and Myh7b) in beta-adrenergically stimulated hearts / Ján Klimas ... [et al.]
    In: European Heart Journal. - Vol. 35, Suppl. 1 (2014), s. 260
  24. AFG Subchronic, but not acute daunorubicin cardiomyopathy is associated with a downregulation of stem cell markers, stem cell factor and vascular endothelial growth factor in the heart / Jasna Šranková ... [et al.]
    In: European Heart Journal. - Vol. 35, Suppl. 1 (2014), s. 894-895
  25. AFG L-arginine administration ameliorates cardiac dysfunction, but does not affect hypertrophy and further downregulates MYH6 expression in isoproterenol-induced heart failure / P. Křenek ... [et al.]
    In: European Heart Journal. - Vol. 34, Suppl. 1 (2013), s. 623-624
  26. AFG Subchronic daunorubicin cardiomyopathy is associated with altered calcium regulation and increased MYH7 and MYH7b expression in rat / J. Klimas ... [et al.]
    In: European Heart Journal. - Vol. 34, Suppl. 1 (2013), s. 772
  27. AFG Protection against ventricular arrhythmias and cardiac SERCA2a upregulation after short-term ACE inhibition in healthy rats / J. Klimas ... [et al.]
    In: Journal of Hypertension. - Vol. 32, Suppl. 1 (2014), s. e549
  28. AFG Combination of antihypertensives alters components of cardiac circadian clock pathway independently of therapy outcome / J. Klimas ... [et al.]
    In: European Heart Journal. - Vol. 38, Suppl. 1 (2017), s. 933
  29. AFG Type 2 diabetes mellitus in patients with terminal stage heart failure / Gabriel Dóka ... [et al.]
    In: Diabetologia. - Roč. 57, suppl. 1 (2014), s. S504
  30. AFG Caveolin-1 alpha expression is decreased in the aorta of rats with glucose intolerance induced by a low dose of streptozotocin / Jasna Šrankova ... [et al.]
    In: Diabetologia. - Roč. 57, suppl. 1 (2014), s. S525
  31. AFG Different expression of CYP enzymes generating vasoactive arachidonic acid metabolites in animal models of glucose intolerance and diabetes / Lenka Piváčková ... [et al.]
    In: Diabetologia. - Roč. 57, suppl. 1 (2014), s. S525
  32. AFG Increased Expression of the Nerve Growth Factor (NGF) in Pulmonary Artery is Accompanied by Changes of Particular Micrornas Levels in Monocrotaline-Induced Pulmonary Hypertension / Zuzana Kmecová ... [et al.]
    In: Journal of Hypertension : ESH 2019 Abstract Book [elektronický dokument]. - Roč. 37, č. 1 (2019), s. e26-e26 [print]
  33. AFG Differences in heart-specific genes expression and cardiac function in physically active rats after repeated administration of testosterone / Ján Kyselovič ...[et al.]
    In: The Biomedical Basis of Elite Performance [elektronický zdroj]. - London : British Pharmacological Society, 2012. - S. 122 [online]
  34. AFG Vplyv G-CSF a inhibítora Dpp4 na expresiu osi Sdf-1/Cxcr4 a markerov kmeňových buniek v srdci potkana s daunorubicínovou kardiomyopatiou / Jasna Šranková ... [et al.]
    In: 65. Česko-slovenské farmakologické dny [elektronický zdroj]. - ISBN 978-80-260-8027-5. - Praha : 1. LF UK a VFN, 2015. - S. 11 [online]
  35. AFG Differential gene expression of important factors in human epicardial adipose tissue and left ventricular myocardium in end-stage heart failure / Jana Mlynárová ... [et al.]
    In: Biomedical Papers. - Vol. 157, Suppl. 1 (2013), S33-S34
  36. AFG Shift in cardiac myosin heavy chain isoforms in sub-acute anthracycline cardiotoxicity / Gabriel Dóka ... [et al.]
    In: Journal of Hypertension. - Vol. 31, eSuppl A (2013), e316-e317
  37. AFG Expression of SDF-1/CXCR4 axis and stem cells markers in anthracycline-induced heart failure in the rat / Jasna Šranková ... [et al.]
    In: Biomedical Papers. - Vol. 157, Suppl. 1 (2013), S42
  38. AFG Selective downregulation of stromal cell derived factor-1 alpha in the right ventricle precedes the development of pulmonary hypertension in monocrotaline-treated rats / Jana Vetešková ... [et al.]
    In: Journal of Hypertension : ESH 2018 Abstract Book. - Roč. 36, č. 1 (2018), s. 46-46
  39. AFG Involvement of microRNAs in isoproterenol-induced cardia damage and potential role in diagnosis / Michal Radik ... [et al.]
    In: Biomedical Papers. - Vol. 157, Suppl. 1 (2013), s. S39
  40. AFG Impact of diabetic state in patients with end-stage heart failure and its association with cardiac expression of micrornas / Gabriel Dóka ... [et al.]
    In: Biomedical Papers. - Vol. 157, Suppl. 1 (2013), S21
  41. AFG Cardiac myosin-isoform shift is accompanied by stable muscle-specific micrornas in monocrotaline-induced pulmonary hypertension / Zuzana Kmecová ... [et al.]
    In: Journal of Hypertension : ESH 2018 Abstract Book. - Roč. 36, č. 1 (2018), s. 45-45
  42. AFG Influence of testosterone on cardiac function, exercise performance and expression of myosin genes in heart and skeletal muscle in physically active rats / Gabriel Dóka ... [et al.]
    In: Journal of Hypertension. - Vol. 30, e-supplement A (2012), s. e78
  43. AFG Adaption of cardiovascular system in physically active rats after repeated administration of testosterone / Ján Kyselovič ... [et al.]
    In: Sudden Cardiac Death & Cardioprotection. Conference and Advanced Resarch Workshop. - ISBN 978-606-8054-80-3. - Timisoara : University of Medicine and Pharmacy of Timisoara, 2012. - S. 33-34
  44. AFG Serum neprilysin concentration as a diagnostics tool in heart failure patients in routine clinical practince / Ján Klimas ... [et al.]
    In: Journal of Hypertension : ESH 2018 Abstract Book. - Roč. 36, č. 1 (2018), s. 217-217
  45. AFG Circadian regulatory genes Per2 and Bmal1 expression changes in combination chronotherapy of hypertension in rats / Michal Radik ... [et al.]
    In: Journal of Hypertension. - Vol. 35, eSuppl 2 (2017), e108
  46. AFG Cardiac stem cells markers and factors affecting their migration and homing decrease in subchronic, but not in acute daunorubicin cardiomyopathy in rat / ... [et al.]
    In: Journal of Hypertension. - Vol. 33, e-Supplement 1 (2015), s. e334
  47. AFG Activation of necroptosis in human end-stage failing hearts / Adrián Szobi ... [et al.]
    In: Journal of Molecular & Cellular Cardiology. - Vol. 86 (2015), s. S39
  48. AFG SDF-1/CXCR4 axis downregulation in daunorubicin cardiomyopathy is partly restored by G-CSF and DPP-4 inhibitor, but this is not associated with increased expression of stem cell markers / Jasna Šranková ... [et al.]
    In: European Heart Journal. - Vol. 36, Suppl. 1 (2015), s. 151-152
  49. AFG Zmeny expresie cirkadiánnych regulátorov v rannej a večernej kombinovanej terapii hypertenzie u potkanov / Michal Radik ... [et al.]
    In: 66. Česko-slovenské farmakologické dny. - ISBN 978-80-260-9782-2. - Brno : Farmakologický ústav LF MU, 2016. - S. 134
  50. AFG Zmeny expresie cirkadiánnych regulátorov v kardiovaskulárnom systéme vplyvom kombinovanej chronoterapie hypertenzie u potkanov / Michal Radik ... [et al.]
    In: Cardiology letters. - Roč. 25, suppl. 1 (2016), s. 22S
  51. AFG High doses of testosterone do not have apparent deleterious effects on heart ventricles in rats, even in combination with spontaneous mild physical activity / Michal Radik ... [et al.]
    In: 65. Česko-slovenské farmakologické dny [elektronický zdroj]. - ISBN 978-80-260-8027-5. - Praha : 1. LF UK a VFN, 2015. - S. 9-10 [online]
  52. AFG Cardiac potassium channels remodelling in experimental diabetic cardiomyopthy / Katarína Hadová ... [et al.]
    In: Journal of Hypertension : ESH 2019 Abstract Book [elektronický dokument]. - Roč. 37, č. 1 (2019), s. e160-e160 [print]
  53. AFG Pharmacological inhibition of vasopressin-induced expression of endothelin-1 in smooth muscle cell culture / Jana Vetešková ... [et al.]
    In: 68. česko-slovenské farmakologické dny [elektronický dokument] : sborník abstrakt. - ISBN 978-80-906595-6-8. - Hradec Králové : Ústav farmakologie, 2018. - S. 140-141 [online]
  54. AFG The impact of the treatment with inorganic nitrates on the right ventricle in monocrotaline-induced pulmonary hypertension / Zuzana Kmecová ... [et al.]
    In: 68. česko-slovenské farmakologické dny [elektronický dokument] : sborník abstrakt. - ISBN 978-80-906595-6-8. - Hradec Králové : Ústav farmakologie, 2018. - S. 53-54 [online]
  55. AFG MicroRNA-208A and its host gene cardiac myosin heavy chain MYH6 are involved in hypertrophic heart dysfunction / Gabriel Dóka ... [et al.]
    In: Journal of Hypertension. - Vol. 33, e-Supplement 1 (2015), s. e1
  56. AFG Sledovanie renalnej expresie mikroRNA v modeli doxorubicínom indukovanej nefrotoxicity / Gabriel Dóka ... [et. al.]
    In: Onkologie. - Roč. 4, suppl. A (2010), s. A34
  57. AFG Expression of endothelin system components during initiation and development of isoproterenol-induced cardiac hypertrophy / L. Piváčková ... [et al.]
    In: 61. česko-slovenské farmakologické dny a EPHAR symposium. - ISBN 978-80-7399-770-0. - Brno : Tribun EU, 2011. - S. 122
  58. AFG Cardiac microRNAs in human end-stage heart failure / Gabriel Dóka ... [et al.]
    In: 61. česko-slovenské farmakologické dny a EPHAR symposium. - ISBN 978-80-7399-770-0. - Brno : Tribun EU, 2011. - S. 46
  59. AFG Vplyv G-CSF a linagliptínu na expresiu cytokínov a komponentov HGF systému v srdci potkana s daunorubicínom indukovanou kardiomyopatiou / Jasna Šranková ... [et al.]
    In: 66. Česko-slovenské farmakologické dny. - ISBN 978-80-260-9782-2. - Brno : Farmakologický ústav LF MU, 2016. - S. 151-152
  60. AFH Odlišné účinky samostatného a súčasného podania k laritromycínu a furosemidu na myokardiálnu génovú expresiu (Kcnq1, Cacna1c, Myh6, Myh7, Myh7b) v beta-adrenergne stimulovaných srdciach / Gabriel Dóka ... [et al.]
    In: 64. Česko-slovenské farmakologické dni; 24. Martinské dni dýchania [elektronický zdroj]. - ISBN 978-80-89544-70-7. - Martin : JLF UK, 2014. - S. 21 [online]
  61. AFH Rozdielna expresia cytochrómov p450 podieľajúcich sa na tvorbe vazoaktívnych metabolitov kyseliny arachidónovej v animálnych modeloch glukózovej intolerancie a diabetu / Lenka Piváčková ... [et al.]
    In: 64. Česko-slovenské farmakologické dni; 24. Martinské dni dýchania [elektronický zdroj]. - ISBN 978-80-89544-70-7. - Martin : JLF UK, 2014. - S. 80 [online]
  62. AFH Srdcová expresia hepatocytárneho rastového faktora v experimentálne navodenom diabete a vplyv crizotinibu / Martin Rupp ... [et al.]
    In: 64. Česko-slovenské farmakologické dni; 24. Martinské dni dýchania [elektronický zdroj]. - ISBN 978-80-89544-70-7. - Martin : JLF UK, 2014. - S. 85 [online]
  63. AFH Vplyv daunorubicínu na expresiu potenciálnych faktorov zúčastňujúcich sa v migrácii a uchytení kmeňových buniek v srdci potkana s navodenou akútnou a subchronickou kardiomyopatiou / Jasna Šranková ... [et al.]
    In: 64. Česko-slovenské farmakologické dni; 24. Martinské dni dýchania [elektronický zdroj]. - ISBN 978-80-89544-70-7. - Martin : JLF UK, 2014. - S. 96 [online]
  64. AFH Cardiac expression of hepatocyte growth factor in experimental diabetes and the influence of crizotinib / Martin Rupp ... [et al.]
    In: Cardiology letters. - Roč. 23, Suppl. 1 (2014), s. 32S
  65. AFH Alterations in L-type calcium channel expression are involved in drug-induced repolarization cardiotoxicity / J. Klimas ... [et al.]
    In: Toxicology Letters. - Roč. 280, Suppl. 1 (2017), s. S161
  66. AFH Potenciál nekódujúcich RNA pre farmakoterapiu a diagnostiku / Gabriel Dóka
    In: Farmaceutický obzor. - Roč. 87, č. 12 (2018), s. 330-331
  67. AFH Zmeny expresie kľúčových faktorov v epikardiálnom tukovom tkanive a v ľavej komore myokardu v konečnom štádiu srdcového zlyhávania / Jana Mlynárová ... [et al.]
    In: Cardiology letters. - Roč. 22, suppl. 2 (2013), s. 29S
  68. AFH Importance of cardiac myosin isoforms in human end-stage heart failure / Gabriel Dóka ... [et al.]
    In: 62. Farmakologické dni. - ISBN 978-80-8143-020-6. - Košice : Equilibria, 2012. - S. 32
  69. AFH Pycnogenol (R) normalizuje komorovú depolarizáciu u diabetickej kardiomyopatie bez ovplyvnenia zvýšenej expresie konexínu 43 / Viera Nemčeková ... [et al.]
    In: 62. Farmakologické dni. - ISBN 978-80-8143-020-6. - Košice : Equilibria, 2012. - S. 73
  70. AFH L-arginín zlepšuje funkciu ľavej komory bez vplyvu na ostatné zmeny u izoprenalínom indukovaného poškodenia srdca / Peter Potúček ... [et al.]
    In: 62. Farmakologické dni. - ISBN 978-80-8143-020-6. - Košice : Equilibria, 2012. - S. 83
  71. AFH Combination of excessive use testosterone and physical activity in rat - beneficial or detrimental? / Gabriel Dóka ... [et al.]
    In: Folia Medica Cassoviensia. - Roč. 67, č. 1, Suppl. 1 (2012), s. 151
  72. AFH Expression dynamics of selected calcium-handling proteins during induction and development of isoproterenol-induced cardiac hypertrophy / Lenka Piváčková ... [et al.]
    In: Folia Medica Cassoviensia. - Roč. 67, č. 1, Suppl. 1 (2012), s. 153-154
  73. AFH Dynamics of HGF system key components in rat model of pulmonary hypertension / Michal Radik ... [et al.]
    In: Interdisciplinary Toxicology. - Vol. 10, suppl. 2 (2017), s. 43
  74. AFH Role of CaMKIIdelta in end-stage human heart failure / Tomáš Rajtík ... [et al.]
    In: Advances in Cardiovascular Research. - ISBN 978-80-224-1452-4. - Bratislava : Veda, 2015. - S. 47
  75. AFH Presence of necroptosis in end-stage human heart failure / Adrián Szobi ... [et al.]
    In: Advances in Cardiovascular Research. - ISBN 978-80-224-1452-4. - Bratislava : Veda, 2015. - S. 55
  76. AFH MikroRNA-208a ako potenciálny plazmatický marker srdcového poškodenia / Michal Radik ... [et al.]
    In: Cardiology letters. - Roč. 22, suppl. 2 (2013), s. 32S
  77. AFH Diabetický status pacienta s terminálnym štádiom srdcového zlyhávania vo vzťahu k ľavokomorovej expresii kardio-relevantných mikroRNA / G. Dóka ... [et al.]
    In: Cardiology letters. - Roč. 22, Suppl. 2 (2013), s. 14S-15S
  78. AFH Porucha kontraktilnej funkcie srdca v srdciach poškodených v dôsledku akútnej a chronickej ischémie vedúcej k srdcovému zlyhaniu: úlohy CaMKIIdelta-sprostredkovanej regulácie cMyBP-C / M. Lichý ... [et al.]
    In: Cardiology letters. - Roč. 24, Suppl. 1 (2015), s. 23S
  79. AFH Zlyhávajúce srdcia sú pozitívne na prítomnosť nekroptotických ale nie apoptotických markerov / Adrián Szobi ... [et al.]
    In: Cardiology letters. - Roč. 24, Suppl. 1 (2015), s. 31S
  80. AFH Vysoké dávky testosterónu nemajú zjavné škodlivé účinky na komorový myokard potkana, a to ani v kombinácii so spontánnou miernou fyzickou aktivitou / Michal Radík ... [et al.]
    In: Cardiology letters. - Roč. 24, Suppl. 1 (2015), s. 29S
  81. AFH Heart failure - microRNA expression / Gabriel Dóka ... [et al.]
    In: Cardiology letters. - Roč. 20, suppl. 1 (2011), s. 11S
  82. AFH Relation of specific transcription factors expression in epicardial adipose tissue and myocardium - GWAS / Jana Mlynárová ... [et al.]
    In: Novel Frontiers in Physiology and Pharmacology of the Cholinergic System. - Bratislava : [s.n.], 2012. - S. 11
  83. AFH NFAT3, TBX18, WT1, CALN, EDN1 and endogenous reference genes expression analysis in epicardial and subcutaneous adipose tissue / Jana Mlynárová ... [et al.]
    In: Novel Frontiers in Physiology and Pharmacology of the Cholinergic System. - Bratislava : [s.n.], 2011. - S. 13-14
  84. BCI Vybrané kapitoly zo špeciálnej klinickej farmakológie a farmakoterapie pre farmaceutov [elektronický dokument] : . / Magdaléna Kuželová ... [et al.]
    Bratislava : Univerzita Komenského v Bratislave, 2020
  85. BFA Crizotinib-Induced Downregulation of Essential RTKs in Rat Heart / Katarína Hadová ... [et al.]
    In: Farmakodny [elektronický dokument] : 69. česko-slovenské farmakologické dny. - [S.l.] : [s.n.], 2019. - S. [1-1] [online]
  86. BFA Dysregulation of LET-7/NGF/MIR-21 Axis in Pulmonary Artery of Monocrotaline-Induced Pulmonary Hypertension in Rats / Zuzana Kmecová ... [et al.]
    In: Farmakodny [elektronický dokument] : 69. česko-slovenské farmakologické dny. - [S.l.] : [s.n.], 2019. - S. [1-1] [online]
  87. BFA Human epicardial adipose tissue shows a higher gene expression compared to left ventricular myocardium in end-stage heart failuzre / Jana Mlynárová ... [et al.]
    In: 21st Meeting of the Alpe Adria Association of Cardiology. - Trieste : [s.n.], 2013. - S. 29
  88. BFA Mechanizmus intracelulárneho hypotyroidizmu v poškodenom myokarde potkanov / E. Babiak ... [et al.]
    In: Farmakodny [elektronický dokument] : 69. česko-slovenské farmakologické dny. - [S.l.] : [s.n.], 2019. - S. [1-1] [online]
  89. BFA Isoform-Specific Alterations of Adrenoreceptors in Monocrotaline-Induced Model of Pulmonary Hypertensio / Katarína Žirová ... [et al.]
    In: Farmakodny [elektronický dokument] : 69. česko-slovenské farmakologické dny. - [S.l.] : [s.n.], 2019. - S. [1-1] [online]
  90. BFA Cardiac micro-RNAs in human end-stage heart failure / Ján Kyselovič ... [et al.]
    In: World Congress of the International Society for Adaptive Medicine. - Bucharest : [s.n.], 2012. - S. 78
  91. BFA Post-translational modifications of CaMKIIdelta in human heart failure: effects on contractile function and arrhythmias / Tomáš Rajtík ... [et al.]
    In: 33rd Meeting of the European Section of ISHR. - Boredaux : Université Bordeaux, 2015. - S. 105
  92. BFB Gene expression profile in human epicardial adipose tissue and left ventricle in end-stage heart failure / Jana Mlynárová ... [et al.]
    In: Novel Frontiers in Physiology and Pharmacology of the Cholinergic System. - Bratislava : [s.n.], 2013. - S. 21-22
  93. BFB Epikardiálne tukové tkanivo vykazuje vyššiu úroveň expresie mnohých dôležitých faktorov v konečnom štádiu srdcového zlyhávania v porovnaní s ľavou komorou / Jana Mlynárová ... [et al.]
    In: 6. Slovensko-česká konferencia klinickej farmakológie. Racionálna a inovatívna farmakoterapia : Účinnosť - Bezpečnosť - Ekonomika. - Bratislava : SSKF, 2013. - S. [l]

Hore